Small-molecule dual inhibitors targeting heat shock protein 90 for cancer targeted therapy

X Xie, N Zhang, X Li, H Huang, C Peng, W Huang… - Bioorganic …, 2023 - Elsevier
Heat shock protein 90, also known as Hsp90, is an extensively preserved molecular
chaperone that performs a critical function in organizing various biological pathways and …

Natural heat shock protein 90 inhibitors in cancer and inflammation

TEMM Costa, NM Raghavendra, C Penido - European Journal of Medicinal …, 2020 - Elsevier
Heat shock protein (HSP) 90 is the most abundant HSPs, which are chaperone molecules
whose major roles are cell protection and maintenance by means of aiding the folding, the …

Upregulated heat shock proteins after hyperthermic chemotherapy point to induced cell survival mechanisms in affected tumor cells from peritoneal carcinomatosis

T Grimmig, EM Moll, K Kloos… - Cancer growth and …, 2017 - journals.sagepub.com
In patients with peritoneal carcinomatosis cytoreductive surgery combined with hyperthermic
intraperitoneal chemotherapy (HIPEC) represents a promising treatment strategy. Here, we …

Rationally modified SNX-class Hsp90 inhibitors disrupt extracellular fibronectin assembly without intracellular Hsp90 activity

GS Mathenjwa, A Chakraborty, A Chakraborty… - RSC Medicinal …, 2024 - pubs.rsc.org
Despite Hsp90's well documented promise as a target for developing cancer
chemotherapeutics, its inhibitors have struggled to progress through clinical trials. This is, in …

The Hsp70 inhibiting peptide aptamer A17 potentiates radiosensitization of tumor cells by Hsp90 inhibition

D Schilling, C Garrido, SE Combs, G Multhoff - Cancer letters, 2017 - Elsevier
The inhibition of heat shock protein 90 (Hsp90) is a promising strategy to increase the
radiosensitivity of tumor cells. However, Hsp90 inhibition induces the expression of Hsp70 …

The first report of direct inhibitors that target the C-terminal MEEVD region on heat shock protein 90

LK Buckton, H Wahyudi, SR McAlpine - Chemical Communications, 2016 - pubs.rsc.org
Sixteen linear and cyclic peptides were designed de novo to target the C-terminus of heat
shock protein 90 (Hsp90). Protein binding data indicates that three compounds directly block …

Regulating the master regulator: Controlling heat shock factor 1 as a chemotherapy approach

JR McConnell, LK Buckton, SR McAlpine - Bioorganic & medicinal …, 2015 - Elsevier
Described is the role that heat shock factor 1 (HSF1) plays in regulating cellular stress.
Focusing on the current state of the HSF1 field in chemotherapeutics we outline the …

Transportable, chemical genetic methodology for the small molecule-mediated inhibition of heat shock factor 1

CL Moore, MB Dewal, EE Nekongo… - ACS chemical …, 2016 - ACS Publications
Proteostasis in the cytosol is governed by the heat shock response. The master regulator of
the heat shock response, heat shock factor 1 (HSF1), and key chaperones whose levels are …

A Novel Class of Hsp90 C‐Terminal Modulators Have Pre‐Clinical Efficacy in Prostate Tumor Cells Without Induction of a Heat Shock Response

HK Armstrong, YC Koay, S Irani, R Das… - The …, 2016 - Wiley Online Library
BACKGROUND While there is compelling rationale to use heat shock protein 90 (Hsp90)
inhibitors for treatment of advanced prostate cancer, agents that target the N‐terminal ATP …

How selective are Hsp90 inhibitors for cancer cells over normal cells?

Y Wang, YC Koay, SR McAlpine - ChemMedChem, 2017 - Wiley Online Library
Selectively inhibiting target proteins in cancer cells over normal cells is one of the most
critical features of a successful protein inhibitor for clinical applications. By evaluating and …